Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.
about
Update in lung cancer and mesothelioma 2012Endothelial protein C receptor function in murine and human breast cancer developmentEndothelial cell protein C receptor: a multiliganded and multifunctional receptorRole of the protein C receptor in cancer progression.Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular DiseaseInfluence of endothelial cell protein C receptor on breast cancer development.Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2.Tissue factor and cancer.New therapeutic targets for cancer bone metastasisBone metastases in lung cancer. Potential novel approaches to therapy.Endothelial protein C receptor is overexpressed in colorectal cancer as a result of amplification and hypomethylation of chromosome 20qTargeting clotting proteins in cancer therapy - progress and challenges.Endothelial cell protein C receptor promotes MGC803 gastric cancer cells proliferation and migration by activating ERK1/2.RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive mannerA gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer.Endothelial cell protein C receptor opposes mesothelioma growth driven by tissue factor.Endothelial protein C receptor polymorphisms and risk of sepsis in a Chinese population.Progress in the research on the mechanism of bone metastasis in lung cancer.EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growthLung cancer: new therapeutic targets, new definitions.Soluble endothelial protein C receptor and coagulation parameters as prognostic factors in non-small cell lung carcinoma.[Advances on mechanisms of coagulation with non-small cell lung cancer].Protein C receptor stimulates multiple signaling pathways in breast cancer cells.TR47, a PAR1-based peptide, inhibits melanoma cell migration in vitro and metastasis in vivo.Endothelial cell protein C receptor-dependent signaling.
P2860
Q24619675-F0854838-D197-4CCF-B860-E381736B0356Q27327182-1A70F20F-B7D0-49A1-81F2-25A07C75E815Q34136982-615C1349-191E-4C67-9712-5DAD76548F2EQ34731385-82292004-9BB5-41C4-8A02-50F9D313D4A7Q37019583-2ADC76F9-4BD1-4D9F-B667-70D5EB88D678Q37138635-272BC735-65F1-4C07-AD99-DB2969528DBCQ37354237-B87AFAE1-638C-4EB0-B9D1-A2D6869FDC1CQ37408325-53088A47-7B71-40A8-BFFA-31AD4E7D7E2FQ37691187-FDCB681C-D57A-414E-B44C-1C4B57FD3712Q38048550-70900A19-30F5-4000-9A6B-6950FDB2DAE1Q38473066-E4F0AB26-7349-4964-93AB-68346A7B9BF5Q38541387-C557B735-36D6-4B76-A711-3DDD1E6F567FQ38695836-EFB42912-0BA2-40C9-89F4-A643B93D16BCQ38805371-BEC2B345-F6D5-4ACD-926E-2074225F3869Q38884309-F3BFB7FC-7CE1-4F06-B4B5-0159128E4077Q39045155-1A770F00-58B5-4E77-9347-99954E6D5AFBQ39069356-67095FAB-91B8-48D6-B47A-9D675CACDB0EQ39173889-ABA9C59A-0E94-4A1B-AEAA-688A1F476178Q40239904-4C07DCBF-6738-4B04-A2CC-F84ABC5DF46DQ41890747-22F972EC-1CC0-4A0F-9369-D5F18620D4BDQ42329454-C7E9B2A1-142B-4D72-B7C6-56B10A8E7516Q42732789-6C2E117F-7FFF-4B8C-83E9-01CB5BB988E6Q44980761-9D0E24C3-4FD4-4A7D-9590-3129F2523445Q44982133-F9DF6D76-022E-4EAA-88F6-416F0299DC5BQ47317600-8C50608D-AFBB-4200-B09F-E9F8A67E2A13Q47340573-774AF36D-944D-4984-9C3C-C9B484B85D3CQ49815107-AD7D7A4D-10C6-4D89-826D-7DC94441685C
P2860
Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Receptor of activated protein ...... utcome in lung adenocarcinoma.
@ast
Receptor of activated protein ...... utcome in lung adenocarcinoma.
@en
type
label
Receptor of activated protein ...... utcome in lung adenocarcinoma.
@ast
Receptor of activated protein ...... utcome in lung adenocarcinoma.
@en
prefLabel
Receptor of activated protein ...... utcome in lung adenocarcinoma.
@ast
Receptor of activated protein ...... utcome in lung adenocarcinoma.
@en
P2093
P2860
P50
P1476
Receptor of activated protein ...... utcome in lung adenocarcinoma.
@en
P2093
Carolina Zandueta
Cristina Ormazabal
Diego Luis-Ravelo
Eva Molina
Fernando Lecanda
Iker Antón
Luis M Montuenga
María José Pajares
Naiara Perurena
Susana Martínez-Canarias
P2860
P304
P356
10.1164/RCCM.201110-1826OC
P407
P577
2012-03-29T00:00:00Z